
Sign up to save your podcasts
Or


BELIEVING IN HOPE WITHOUT COMPROMISE. Dr Virgilio Sacchini is dedicated to caring for people with breast cancer at the Memorial Sloan Kettering Cancer Center in New York. He originally trained at Universita degli Studi di Milano (UNIMI, Milan, Italy) where he is Professor of Surgery, and cooperates with the European Institute of Oncology in Milan (IEO, Milan, Italy). Dr Sacchini is a 2023 and 2024 Castle Connolly America's Top Doctor, the peer nominated group of the top 7% of all US practicing physicians. His goal is to achieve the best possible cancer outcomes and cosmetic results for his patients.
"The new concept is to target only cancer cells."
"To cure someone and give him or her a miserable life is terrible, so the target in this moment is both better survival and better quality of life, less side effects."
"Once we prove that the combination of the medication with the Avacta technique works, of course it is approved and you can be cured everywhere in the world."
By Alain Elkann4.3
66 ratings
BELIEVING IN HOPE WITHOUT COMPROMISE. Dr Virgilio Sacchini is dedicated to caring for people with breast cancer at the Memorial Sloan Kettering Cancer Center in New York. He originally trained at Universita degli Studi di Milano (UNIMI, Milan, Italy) where he is Professor of Surgery, and cooperates with the European Institute of Oncology in Milan (IEO, Milan, Italy). Dr Sacchini is a 2023 and 2024 Castle Connolly America's Top Doctor, the peer nominated group of the top 7% of all US practicing physicians. His goal is to achieve the best possible cancer outcomes and cosmetic results for his patients.
"The new concept is to target only cancer cells."
"To cure someone and give him or her a miserable life is terrible, so the target in this moment is both better survival and better quality of life, less side effects."
"Once we prove that the combination of the medication with the Avacta technique works, of course it is approved and you can be cured everywhere in the world."

6,812 Listeners

578 Listeners

214 Listeners

5,477 Listeners

2,451 Listeners

1,206 Listeners

214 Listeners

433 Listeners

500 Listeners

351 Listeners

140 Listeners

15,258 Listeners

291 Listeners

81 Listeners

12 Listeners